TCL Archive Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort November 24, 1995
TCL Archive Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report October 10, 1997
TCL Archive Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds March 28, 2003
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
